Cirrhosis Clinical Trials in Dallas, Texas
8 recruitingDallas, Texas
Showing 1–8 of 8 trials
Recruiting
Phase 2
A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH)
Liver Cirrhosis
Boehringer Ingelheim30 enrolled27 locationsNCT07325526
Recruiting
Not Applicable
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Carcinoma, HepatocellularCirrhosis
VA Office of Research and Development4,700 enrolled32 locationsNCT05486572
Recruiting
Phase 4
National Liver Cancer Screening Trial
Liver CancerCarcinoma, HepatocellularLiver Cirrhosis+1 more
University of Texas Southwestern Medical Center5,500 enrolled18 locationsNCT06084234
Recruiting
Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs
Liver Transplant; ComplicationsLiver CirrhosisLiver Diseases+1 more
European Foundation for Study of Chronic Liver Failure3,000 enrolled106 locationsNCT04613921
Recruiting
Phase 2
Safety and Efficacy of Atorvastatin v. Placebo on HCC Risk
CirrhosisLiver Fibroses
Raymond Chung60 enrolled2 locationsNCT05028829
Recruiting
Phase 1
Single and Multiple Dose Escalation of PHIN-214 in Child-Pugh A and B Liver Cirrhotics
Cirrhosis, LiverLiver FibrosisAscites Hepatic
PharmaIN74 enrolled9 locationsNCT05490888
Recruiting
Phase 2
EGCG for Hepatocellular Carcinoma Chemoprevention
Cirrhosis, Liver
University of Texas Southwestern Medical Center60 enrolled1 locationNCT06015022
Recruiting
Phase 3
Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis
Hepatocellular CarcinomaCirrhosis
Can-Fite BioPharma471 enrolled32 locationsNCT05201404